Literature DB >> 16226541

Optical coherence tomography findings in tamoxifen retinopathy.

Vincent Gualino1, Salomon Y Cohen, Marie-Noëlle Delyfer, José-Alain Sahel, Alain Gaudric.   

Abstract

PURPOSE: To describe optical coherence tomography (OCT) findings in two cases of typical tamoxifen retinopathy.
DESIGN: Observational cases report.
METHODS: Two patients with tamoxifen retinopathy were imaged with fluorescein angiography and OCT 3.
RESULTS: Fluorescein angiography showed foveolar hyperfluorescence. OCT revealed a foveolar cystoid space with focal disruption of the photoreceptor line. There was no evidence of macular edema or thickening.
CONCLUSIONS: In both cases, OCT findings are not consistent with previous descriptions of tamoxifen retinopathy, based on fundus examination and fluorescein angiography, which include a description of macular edema. This new imaging suggests that tamoxifen maculopathy may include a foveolar cystoid space different from macular edema.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226541     DOI: 10.1016/j.ajo.2005.04.042

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  Macular cysts, holes and cavitations : 2006 Jules Gonin lecture of the Retina Research Foundation.

Authors:  A Gaudric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-30       Impact factor: 3.117

2.  The use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina.

Authors:  Joseph A Majdi; Haohua Qian; Yichao Li; Robert J Langsner; Katherine I Shea; Anant Agrawal; Daniel X Hammer; Joseph P Hanig; Ethan D Cohen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-18       Impact factor: 4.799

3.  [Morphological characteristics in macular telangiectasia type 2].

Authors:  P Charbel Issa; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

4.  [Unusual symptoms for tamoxifen-associated maculopathy].

Authors:  T Hager; S Hoffmann; B Seitz
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

5.  Microcystoid maculopathy associated with tamoxifen use diagnosed by high-resolution fourier-domain optical coherence tomography.

Authors:  Susanna S Park; Robert J Zawadzki; Steven N Truong; Stacey S Choi; John S Werner
Journal:  Retin Cases Brief Rep       Date:  2009

6.  Estrogen antagonist and development of macular hole.

Authors:  Song Ee Chung; Seong Wook Kim; Hye Won Chung; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2010-10-05

7.  Maculopathy diagnosed with high-resolution fourier-domain optical coherence tomography in eyes with previously unexplained visual loss.

Authors:  Susanna S Park; Robert J Zawadzki; Stacey S Choi; John S Werner
Journal:  Retin Cases Brief Rep       Date:  2010

Review 8.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

9.  [Tamoxifen retinopathy: a case series of clinical and functional data].

Authors:  C Ritter; A B Renner; J Wachtlin; N E Bechrakis; L Krause
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

10.  Retinal function in patients treated with tamoxifen.

Authors:  Sung Eun Song Watanabe; Adriana Berezovsky; Márcia Motono; Paula Yuri Sacai; Josenilson Martins Pereira; Juliana Maria Ferraz Sallum; Luiz Henrique Gebrim; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.